BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27633248)

  • 1. A candidate Chinese medicine preparation-Fructus Viticis Total Flavonoids inhibits stem-like characteristics of lung cancer stem-like cells.
    Cao X; Zou H; Cao J; Cui Y; Sun S; Ren K; Song Z; Li D; Quan M
    BMC Complement Altern Med; 2016 Sep; 16():364. PubMed ID: 27633248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
    World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt.
    Liu F; Cao X; Liu Z; Guo H; Ren K; Quan M; Zhou Y; Xiang H; Cao J
    Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):15-21. PubMed ID: 24247269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.
    Wen Q; Xu C; Zhou J; Liu NM; Cui YH; Quan MF; Cao JG; Ren KQ
    BMC Cancer; 2019 Mar; 19(1):224. PubMed ID: 30866863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Bromo-7-methoxychrysin-blocked STAT3/Twist axis inhibits the stemness of cancer stem cell-like cell originated from SMMC-7721 cells.
    Luo Y; Cui Y; Cao X; Li X; Chen A; Zhang J; Chen X; Cao J
    Acta Biochim Biophys Sin (Shanghai); 2017 May; 49(5):458-464. PubMed ID: 28369327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isovitexin Suppresses Stemness of Lung Cancer Stem-Like Cells through Blockage of MnSOD/CaMKII/AMPK Signaling and Glycolysis Inhibition.
    Liu F; Yuan Q; Cao X; Zhang J; Cao J; Zhang J; Xia L
    Biomed Res Int; 2021; 2021():9972057. PubMed ID: 34195288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway.
    Lu C; Huang T; Chen W; Lu H
    Oncol Rep; 2015 Jul; 34(1):244-50. PubMed ID: 25955300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casticin suppresses the carcinogenesis of small cell lung cancer H446 cells through activation of AMPK/FoxO3a signaling.
    Gong Q; Cao X; Cao J; Yang X; Zeng W
    Oncol Rep; 2018 Sep; 40(3):1401-1410. PubMed ID: 30015975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction.
    Wang L; Guo H; Yang L; Dong L; Lin C; Zhang J; Lin P; Wang X
    Mol Cell Biochem; 2013 Jul; 379(1-2):7-18. PubMed ID: 23543150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line.
    Zou H; Cao X; Xiao Q; Sheng X; Ren K; Quan M; Song Z; Li D; Zheng Y; Zeng W; Cao J; Peng Y
    Oncol Rep; 2016 Sep; 36(3):1731-8. PubMed ID: 27461522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puerarin 6″-O-xyloside suppresses growth, self-renewal and invasion of lung cancer stem-like cells derived from A549 cells via regulating Akt/c-Myc signalling.
    Tao X; Yin Y; Lian D; Gu H; Chen W; Yang L; Yin G; Liu P; Li L; Wei Y; Xie Z; Liu F; Sui H; Yan D; Tao W
    Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1311-1319. PubMed ID: 32124474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression.
    Jiang P; Li F; Liu Z; Hao S; Gao J; Li S
    Respir Res; 2021 Dec; 22(1):320. PubMed ID: 34949193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
    Lin CS; Bamodu OA; Kuo KT; Huang CM; Liu SC; Wang CH; Tzeng YM; Chao TY; Yeh CT
    Phytomedicine; 2018 Jul; 46():93-103. PubMed ID: 30097127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
    Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of liver cancer-associated stellate cell-induced stem-like characteristics in SMMC-7721 cells by 8-bromo-7-methoxychrysin via inhibiting STAT3 activation.
    Cui Y; Sun S; Ren K; Quan M; Song Z; Zou H; Li D; Cao J
    Oncol Rep; 2016 May; 35(5):2952-62. PubMed ID: 26935885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein inhibits lung cancer cell stem-like characteristics by modulating MnSOD and FoxM1 expression.
    Fu Z; Cao X; Liu L; Cao X; Cui Y; Li X; Quan M; Ren K; Chen A; Xu C; Qiu Y; Chen X; Wang Z; Cao J
    Oncol Lett; 2020 Sep; 20(3):2506-2515. PubMed ID: 32782570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.